HDAC8-IN-3
HDAC8-IN-3 (compound P19) is a potent HDAC8 inhibitor with IC50 value of 9.3 μM and produces thermal stabilization. HDAC8-IN-3 has cytotoxicity and induces apoptosis in leukemic cell lines[1].
Product Specifications
CAS Number
2432825-93-7
UNSPSC
12352005
Target
Apoptosis; HDAC
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac8-in-3.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=NC2=CC=CC=C2S1)CN(C/3=O)C(SC3=C\C4=NC=CC=C4)=O
Molecular Formula
C18H12N4O3S2
Molecular Weight
396.44
References & Citations
[1]Upadhyay N, et al. Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation. Bioorg Chem. 2020 Jul;100:103934.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC8
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0060883-02 100 µL
Monoclonal Antibody to Filamin A Alpha (FLNa)
Sign In for Pricing
View Details TRV-0060883-03 200 µL
Monoclonal Antibody to Filamin A Alpha (FLNa)
Sign In for Pricing
View Details TMAC-00019-02 100 µL
Anti-Phospho-4EBP1 (Thr69) Polyclonal Antibody
Sign In for Pricing
View Details